Physical comorbidity and use of healthcare services in people with schizophrenia: protocol for a systematic review

BMJ Open. 2021 Dec 14;11(12):e053324. doi: 10.1136/bmjopen-2021-053324.

Abstract

Introduction: People with schizophrenia die about 15-20 years earlier than the general population. A constellation of factors contributes to this gap in life expectancy: side effects of psychotropic drugs, unhealthy lifestyles (inactivity, unhealthy diet) and inequality in the provision of healthcare services. This is a topic of main importance, which requires constant update and synthesis of the literature. The aim of this review is to explore the evidence of physical comorbidity and use of healthcare services in people with schizophrenia.

Methods and analysis: We will conduct a systematic literature search in the databases PubMed/MEDLINE, EMBASE, Scopus, Web of Science, PsycINFO and Cochrane Library, Proquest Health Research Premium Collection, in order to identify studies that answer to our research question: Are patients with schizophrenia different from the non-psychiatric population in terms of physical comorbidity and use of healthcare services? Two authors will independently review the studies and extract the data.

Ethics and dissemination: This study does not include human or animal subjects. Thus, ethics considerations are not applicable. Dissemination plans include publications in peer-reviewed journals and discussion of results in psychiatric congresses.

Prospero registration number: CRD42020139972.

Keywords: epidemiology; mental health; schizophrenia & psychotic disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Comorbidity
  • Delivery of Health Care
  • Health Services
  • Humans
  • Psychotropic Drugs
  • Schizophrenia* / epidemiology
  • Schizophrenia* / therapy
  • Systematic Reviews as Topic

Substances

  • Psychotropic Drugs